Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis

Rakesh Bhatia1, Jawed Akhtar Siddiqui1,2, Koelina Ganguly1

  • 1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.

Oncogene
|January 9, 2023
PubMed

Insights

Mucin4 (MUC4) protein promotes pancreatic cancer by stabilizing epidermal growth factor receptor (EGFR) signaling. Depleting MUC4 delays tumor formation and reduces EGFR activity, offering a new therapeutic target for pancreatic ductal adenocarcinoma (PDAC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Mucin4 (MUC4) expression is an early event in pancreatic intraepithelial neoplasia (PanIN), coinciding with epidermal growth factor receptor (EGFR) signaling, which is crucial for Kras-driven pancreatic ductal adenocarcinoma (PDAC).
  • The precise mechanisms sustaining EGFR signaling in early PanIN lesions remain unclear.

Purpose of the Study:

  • To investigate the role of MUC4 in PDAC development and EGFR signaling using a conditional knockout murine model.
  • To elucidate the molecular interaction between MUC4 and EGFR in PDAC pathogenesis.

Main Methods:

  • Generation of a Muc4 conditional knockout murine model (KPCM4-/-) with K-ras and p53 mutations.
  • Analysis of PanIN lesion formation, EGFR and ERK1/2 phosphorylation, and Sox9 expression in KPCM4-/- mice.
  • Biochemical assays to determine the interaction interface between MUC4 and EGFR.

Main Results:

  • Muc4 depletion significantly delayed PanIN lesion formation in KPCM4-/- mice.
  • Reduced phosphorylation of EGFR (Y1068) and ERK1/2 (T202/Y204) was observed in PanIN lesions of KPCM4-/- mice.
  • Decreased Sox9 expression indicated impaired acinar-to-ductal metaplasia in MUC4-depleted cells, and MUC4 was shown to prevent EGFR ubiquitination and degradation.

Conclusions:

  • MUC4 interacts with EGFR, stabilizing its signaling pathway by preventing degradation.
  • Targeting the MUC4-EGFR interaction interface presents a potential therapeutic strategy for PDAC and other MUC4-expressing cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K